Corporate Reputations Improve During a Year of Crises according to The RepTrak Company
12.4.2021 12:00:00 EEST | Business Wire | Press release
The RepTrak Company™, the world’s leading reputation data and insights company, announces the results of the 2021 Global RepTrak® 100. The report is the world’s most comprehensive reputation study, compiled for the past 11 years using RepTrak’s in-depth analysis and ranking of the top 100 companies worldwide by Reputation Score.
In 2021, RepTrak found that, overall, it was a much more difficult year to break into the top 100. The average score (on a scale of 1-100) was almost 75, the highest in 11 years. This is an indication of the rigorous reputation management in place among these leaders. Several of the companies that rank highest in the 2021 Global RepTrak 100 are those that have implemented ESG (Environment, Societal impact and Governance) initiatives within their global strategies.
Notable findings include:
- Being relevant mattered in a difficult year. Consumer durables and apparel, technology (both hardware and software) and household and personal products companies lead the way after a year when the world depended on them for productivity, entertainment, comfort and safety.
- Pharmaceutical industry’s Reputation Score improved from “average” to “strong” with vaccines propelling positive perceptions. Sanofi S.A., Eli Lilly Company and Bristol Myers Squibb are among the top 10 for Reputation Score growth this year.
- ESG leadership went to the pharmaceutical and household and personal products industries. The global respondents credited their ESG initiatives more than any other industries, another indication of the importance of pandemic-centered relevance in 2020.
- GenZ (18-25) and Millennial (26-40) perceptions differ. GenZ perceives corporations with the greatest skepticism, as indicated by their weaker levels of support for the seven drivers of corporate reputation codified by RepTrak. Millennials were the most positive of all generational segments. GenX (41-55) and Boomers (56-64) fall in the middle and don’t differ greatly.
For the complete 2021 Global RepTrak 100 ranking and report, with comprehensive analysis of global, industry, and demographic trends, visit https://www.reptrak.com/rankings/
2021’s Reputation Leaders
The top 10 companies by Reputation Score, as ranked in the 2021 Global RepTrak® 100, are:
- The Lego Group
- Rolex SA
- Ferrari N.V.
- The Bosch Group
- Harley-Davidson, Inc.
- Canon Inc.
- adidas AG
- The Walt Disney Company
- Microsoft Corp.
- Sony Group Corp.
The Lego Group maintains its #1 ranking, showing a steady increase in Reputation Score over the last several years, with all others in the top 10 in a new position compared to last year’s report. These year over year changes indicate that a company must continually work to improve its reputation and stay relevant.
High Growth in a Challenging Year
The top ten (10) of the 100 companies rated by greatest reputation increases and positive movement in their ranking are: Unilever PLC; Mars, Incorporated; Cisco Systems, Inc.; The Samsung Group; Sanofi S.A.; Harley-Davidson, Inc.; HP Inc.; Procter & Gamble Company; Eli Lilly and Company; and Bristol Myers Squibb.
“At Cisco, we take our reputation seriously. Our purpose as a company is to power an inclusive future for all, and this drives everything we do. We believe it starts with the trust of our stakeholders to look after our people, our communities and our planet. This goes hand in hand with our relentless focus on innovation, to provide more choice and opportunities for our customers. The last year has been difficult for many, so it’s truly inspiring to be recognized for the impact we are making, and spurs us onwards to do more,” shared Gerri Elliot, EVP and Chief Sales and Marketing Officer at Cisco Systems, Inc.
“For Mars, building trust is a key business metric,” said Andy Pharoah, Vice President of Corporate Affairs & Sustainability at Mars, Incorporated, “And we believe maintaining a strong reputation is central to our ability to achieve our goals and live up to our purpose – that the world we want tomorrow starts with how we do business today. In the past year, which has been unlike any other, it’s more important than ever for businesses like Mars to communicate regularly and frequently with our stakeholders and Associates. Success is about navigating the challenges of the day with clarity, empathy and integrity. These results demonstrate that our efforts are having a positive impact, and are being recognized more broadly.”
Eighteen (18) companies are new to the Global RepTrak this year, the largest number of newcomers in the Global RepTrak 100 since its inception 11 years ago. These new entrants include luxury fashion leaders (Chanel Inc, Hermès, Prada Group, Burberry Group Plc), travel and automotive industry names (Volvo Group, Booking.com, Continental AG), consumer companies (Costco Wholesale Corporation, ALDI GmbH & Co. KG, Mattel, Inc.) and other leaders: Space Exploration Technologies Corp. (SpaceX), BIC, Adobe Systems, Hewlett Packard Enterprise, PayPal, Henkel AG & Co.
ESG rises in importance
ESG stands for Environmental, Social impact and Governance issues. The Global RepTrak 100 results clearly show that there is a strong correlation between companies that adhere to high ESG standards and companies that score favorably on the 2021 Global RepTrak 100.
“ESG is being used for the first time this year as a measurable component of reputation, and we can see firsthand why this is so important for 2021 and beyond. There is a strong correlation between companies who hold themselves to high standards, and companies who rank highly on the 2021 Global RepTrak® 100,” says Kylie Wright-Ford, CEO of The RepTrak Company. “Stakeholders have access to more information than ever before, which is empowering them to make more informed decisions. Companies must not only deliver a quality product, but also show that they are doing so in an ethical and globally considerate way.”
RepTrak is the only provider of data and insights around ESG perception at a global scale. For Environment, RepTrak looks at how companies are perceived with regard to climate change, the use of resources and the minimization of its carbon footprint. Social investigates perceptions of how companies lead on human rights, their participation in their local communities and how they handle employees and customers. Governance relates to the leadership, ethics and rights of shareholders and other stakeholders.
Report and Methodology
RepTrak helps companies understand how stakeholders feel, think, and act towards them, measuring reputation using a 0-100 scale and tracking how a company is perceived across several reputation drivers: Products & Services, Innovation, Citizenship, Performance, Governance, Leadership and Workplace. RepTrak’s proprietary measurement system has been developed to allow worldwide application on a normative scale, which enables direct comparison regardless of sector, size, or geography.
For consideration in the 2021 Global RepTrak® 100, a company had to meet the following criteria:
- Be a corporate brand with global revenue above USD $2 billion
- Achieve a global average familiarity threshold above 20 percent in all fifteen countries measured and a familiarity threshold above 20 percent in eight or more of the fifteen countries measured
- Reach a qualifying Reputation Score above the median score (i.e., 67.3 points)
To determine the ranking, The RepTrak Company analyzed reputation data for several thousand companies which was collected between December 2020 and January 2021 using world class survey methodology and was enriched by RepTrak’s historical database. Companies that met these criteria were then ranked based on their global Reputation Scores. A company’s corporate reputation is determined using RepTrak’s proprietary and patent-pending Reputation Score - a score from 0-100 that measures how people feel towards a particular company. Reputation Scores demonstrate a strong positive relationship with business outcomes, such as an audience’s willingness to buy, recommend, or trust a company. The top 100 companies with the highest Reputation Scores made the final ranking.
The Global RepTrak® 100 ranking is based on 68,577 respondents collected across the 15 largest economies globally using online surveys. For access to the report, visit https://www.reptrak.com/rankings/
About RepTrak
The RepTrak Company™ is the world’s leading reputation data and insights company. We provide the only global platform for data-driven insights on Reputation, Brand, and ESG. Our proprietary RepTrak® model is the global standard for measuring and analyzing the sentiment of the world using proven data science models and machine learning techniques across industries and geographies.
Subscribers to the RepTrak® Program use our predictive insights to protect business value, improve return on investment, and increase their positive impact on society.
Established in 2004, The RepTrak Company owns the world’s largest reputation benchmarking database of over 1 million company ratings per year used by CEOs, boards, and executives in more than 60 countries worldwide. For more information, please visit www.reptrak.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210412005413/en/
Contact information
PR Contact: Amanda Donnelly / PR Hacker / RepTrak@PRHacker.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
